Task: Answer the multiple-choice question.
Question: Which drug exhibits a -5.625% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
[a] CCCNC(=O)c1cccc(COCC(F)(F)C(F)F)c1
[b] Cc1ccc(Cn2cccc2/C=C2/C(=N)N3C=CSC3=NC2=O)cc1
[c] Cc1nn(-c2ccccc2)c2c1C(c1ccc(F)cc1F)C(C#N)=C(N)O2
Answer: a. CCCNC(=O)c1cccc(COCC(F)(F)C(F)F)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCNC(=O)c1cccc(COCC(F)(F)C(F)F)c1
CCCNC(=O)c1cccc(COCC(F)(F)C(F)F)c1
N-propyl-3-(2,2,3,3-tetrafluoropropoxymethyl)benzamide